Latest University News

Tailwind for KENUP‘s European Initiative

2015-03-20 KENUP Consortium exemplifies Juncker’s Investment Plan for Europe

Brussels / Lüneburg. At yesterday’s plenary session of the European Economic and Social Committee (EESC), the KENUP consortium, coordinated by Leuphana University of Lüneburg, has been once again brought into play as a model for the implementation of the Investment Plan for Europe. The EESC is a consultative body of the European Union, bridging Europe with Civil Society. Committee member Peter Clever spoke at the meeting in favor of using the EU's multi-billion Euro investment plan to promote powerful industry-specific platforms. For him, the KENUP network, with its 67 partners is a promising example.

Peter Clever is member of the Confederation of German Employers' Associations’ (BDA) managing team and represents the group of European employers in the European Economic and Social Committee. He sees KENUP‘s direction in the innovation of health and life sciences as particularly seminal. In the past, far too little has been invested in this area. Furthermore, it'll be especially important to renew outdated regulatory systems and to create transparent processes. KENUP´s integrated approach with its "Made in Europe platform" may be, in his opinion, the right way to improve the investment environment in Europe.

The "Investment Plan for Europe" was a central theme of the Economic and Social Committee’s meeting. A corresponding regulation for the European Fund for Strategic Investments (EFSI) is currently in the legislative process between the Commission, Parliament and Council. Consulting this process Leuphana Vice-President Holm Keller presented KENUP’s detailed concept for an intervention system in early March at a hearing of the Budget Committee and the Committee on Economic and Monetary Affairs of the European Parliament. The Parliamentarians had appreciated KENUP’s pragmatic approach and the potential of the already established partnership network.

KENUP is a platform that promotes essential innovation in the health sector. Application of life science in the fields of adult immunization and personalized medicine holds a special focus within the consortium’s portfolio. The consortium is coordinated by Leuphana University of Lüneburg. It consists of 67 partners from 19 European countries, the Middle East, the US and China. Its members are the Governments of Malta and Croatia, the World Health Organization (WHO), Israel's National Innovation Program for Personalized Medicine, programs in Jordan and Palestine, some of the world's top universities and research institutions - among them the Program on Global Demography of Aging at Harvard University, MIT Media Lab, the Weizmann Institute and the University of Zurich – as well as influential civil society institutions and 24 innovative companies.